Merck says it is buying Inspire Pharmaceuticals for about $430 million in a move to expand its product portfolio with treatments for eye conditions.
MiamiHerald.com: Business, Miami Herald: Business
Tue, 04/05/2011 - 7:20am
Merck says it is buying Inspire Pharmaceuticals for about $430 million in a move to expand its product portfolio with treatments for eye conditions.